| Amanda Courtney Robinson, | |
|
474 W 200 N, St George, UT 84770-4505 | |
| (435) 634-5600 | |
| Not Available |
| Full Name | Amanda Courtney Robinson |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 474 W 200 N, St George, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073777405 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Courtney Robinson, Po Box 257, Parowan, UT 84761-0257 Ph: (435) 590-7670 | Amanda Courtney Robinson, 474 W 200 N, St George, UT 84770-4505 Ph: (435) 634-5600 |
News Archive
Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
Treatment with vaginal progesterone reduced the risk of preterm birth, neonatal complications and death in pregnant women with twins and who have a short cervix— a risk factor for preterm birth— according to a meta-analysis of individual patient data by researchers at the National Institutes of Health, the Wayne State University School of Medicine, the Detroit Medical Center, and other institutions in the United States and abroad.
Survivors of Ebola virus disease in Liberia had a higher prevalence of certain health issues-including uveitis (eye redness and pain), abdominal, chest, neurologic, and musculoskeletal abnormalities upon physical exam-when compared to a control group of household and community members who did not have a history of EVD, according to findings from an ongoing study published in the New England Journal of Medicine.
Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease.
Idaho Technology's Joint Biological Agent Identification and Diagnostic System (JBAIDS) has been approved by the military to run tests for the H1N1 virus. Deployed across the globe, including in Iraq and Afghanistan, by all four branches of the military, the JBAIDS instrument will be used to test military personnel and their families for Influenza A, swine flu A and H1 swine flu in less than an hour.
› Verified 1 days ago
Lukas Hildebrandt, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1067 E Tabernacle St Ste 7, St George, UT 84770 Phone: 801-255-5131 | |
Jan Hadlock, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1492 S Silicon Way Ste A, St George, UT 84770 Phone: 435-275-8911 | |
Andrew J Weibert, Counselor Medicare: Not Enrolled in Medicare Practice Location: 225 N Bluff St Ste 5, St George, UT 84770 Phone: 435-229-9177 | |
Jason Reynolds, Counselor Medicare: Not Enrolled in Medicare Practice Location: 348 E 600 S, St George, UT 84770 Phone: 435-705-7574 | |
Sarah Cowley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 474 W 200 N, Suite 300, St George, UT 84770 Phone: 435-634-5621 Fax: 435-986-8700 | |
Kiley Shelly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1067 E Tabernacle St, Suite 7, St George, UT 84770 Phone: 801-255-5131 Fax: 801-255-5131 | |
Samantha Montag, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1492 S Silicon Way Ste A, St George, UT 84770 Phone: 435-275-8911 |